182 related articles for article (PubMed ID: 35227456)
1. Performance of the UK Prospective Diabetes Study Outcomes Model 2 in a Contemporary UK Type 2 Diabetes Trial Cohort.
Keng MJ; Leal J; Mafham M; Bowman L; Armitage J; Mihaylova B
Value Health; 2022 Mar; 25(3):435-442. PubMed ID: 35227456
[TBL] [Abstract][Full Text] [Related]
2. Performance of the UKPDS Outcomes Model 2 for Predicting Death and Cardiovascular Events in Patients with Type 2 Diabetes Mellitus from a German Population-Based Cohort.
Laxy M; Schöning VM; Kurz C; Holle R; Peters A; Meisinger C; Rathmann W; Mühlenbruch K; Kähm K
Pharmacoeconomics; 2019 Dec; 37(12):1485-1494. PubMed ID: 31350720
[TBL] [Abstract][Full Text] [Related]
3. Estimating risk factor progression equations for the UKPDS Outcomes Model 2 (UKPDS 90).
Leal J; Alva M; Gregory V; Hayes A; Mihaylova B; Gray AM; Holman RR; Clarke P
Diabet Med; 2021 Oct; 38(10):e14656. PubMed ID: 34297424
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of the CHIME simulation model to assess lifetime health outcomes of prediabetes and type 2 diabetes in Chinese populations: A modeling study.
Quan J; Ng CS; Kwok HHY; Zhang A; Yuen YH; Choi CH; Siu SC; Tang SY; Wat NM; Woo J; Eggleston K; Leung GM
PLoS Med; 2021 Jun; 18(6):e1003692. PubMed ID: 34166382
[TBL] [Abstract][Full Text] [Related]
5. Prediction of mortality and major cardiovascular complications in type 2 diabetes: External validation of UK Prospective Diabetes Study outcomes model version 2 in two European observational cohorts.
Pagano E; Konings SRA; Di Cuonzo D; Rosato R; Bruno G; van der Heijden AA; Beulens J; Slieker R; Leal J; Feenstra TL
Diabetes Obes Metab; 2021 May; 23(5):1084-1091. PubMed ID: 33377255
[TBL] [Abstract][Full Text] [Related]
6. UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82.
Hayes AJ; Leal J; Gray AM; Holman RR; Clarke PM
Diabetologia; 2013 Sep; 56(9):1925-33. PubMed ID: 23793713
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes Study.
Davis WA; Colagiuri S; Davis TM
Med J Aust; 2009 Feb; 190(4):180-4. PubMed ID: 19220181
[TBL] [Abstract][Full Text] [Related]
8. Performance of the UKPDS outcomes model for prediction of myocardial infarction and stroke in the ADDITION-Europe trial cohort.
Tao L; Wilson EC; Griffin SJ; Simmons RK;
Value Health; 2013; 16(6):1074-80. PubMed ID: 24041358
[TBL] [Abstract][Full Text] [Related]
9. Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus.
Lutgers HL; Gerrits EG; Graaff R; Links TP; Sluiter WJ; Gans RO; Bilo HJ; Smit AJ
Diabetologia; 2009 May; 52(5):789-97. PubMed ID: 19274450
[TBL] [Abstract][Full Text] [Related]
10. Validating the UK prospective diabetes study outcome model 2 using data of 94,946 Israeli patients with type 2 diabetes.
Zhuo X; Melzer Cohen C; Chen J; Chodick G; Alsumali A; Cook J
J Diabetes Complications; 2022 Jan; 36(1):108086. PubMed ID: 34799250
[TBL] [Abstract][Full Text] [Related]
11. Comparison of prediction models for cardiovascular and mortality risk in people with type 2 diabetes: An external validation in 23 685 adults included in the UK Biobank.
Zhang Y; Jiong OX; Tang S; Tang YC; Wong CT; Ng CS; Quan J
Diabetes Obes Metab; 2024 May; 26(5):1697-1705. PubMed ID: 38297974
[TBL] [Abstract][Full Text] [Related]
12. Refitting of the UKPDS 68 risk equations to contemporary routine clinical practice data in the UK.
McEwan P; Bennett H; Ward T; Bergenheim K
Pharmacoeconomics; 2015 Feb; 33(2):149-61. PubMed ID: 25344660
[TBL] [Abstract][Full Text] [Related]
13. Macrovascular Risk Equations Based on the CANVAS Program.
Willis M; Asseburg C; Slee A; Nilsson A; Neslusan C
Pharmacoeconomics; 2021 Apr; 39(4):447-461. PubMed ID: 33580867
[TBL] [Abstract][Full Text] [Related]
14. Validation of Risk Equations for Complications of Type 2 Diabetes (RECODe) Using Individual Participant Data From Diverse Longitudinal Cohorts in the U.S.
Basu S; Sussman JB; Berkowitz SA; Hayward RA; Bertoni AG; Correa A; Mwasongwe S; Yudkin JS
Diabetes Care; 2018 Mar; 41(3):586-595. PubMed ID: 29269511
[TBL] [Abstract][Full Text] [Related]
15. Long-term risk of cardiovascular disease in individuals with latent autoimmune diabetes in adults (UKPDS 85).
Maddaloni E; Coleman RL; Pozzilli P; Holman RR
Diabetes Obes Metab; 2019 Sep; 21(9):2115-2122. PubMed ID: 31099472
[TBL] [Abstract][Full Text] [Related]
16. Time-varying risk of microvascular complications in latent autoimmune diabetes of adulthood compared with type 2 diabetes in adults: a post-hoc analysis of the UK Prospective Diabetes Study 30-year follow-up data (UKPDS 86).
Maddaloni E; Coleman RL; Agbaje O; Buzzetti R; Holman RR
Lancet Diabetes Endocrinol; 2020 Mar; 8(3):206-215. PubMed ID: 32032540
[TBL] [Abstract][Full Text] [Related]
17. Estimated incidence of cardiovascular complications related to type 2 diabetes in Mexico using the UKPDS outcome model and a population-based survey.
Reynoso-Noverón N; Mehta R; Almeda-Valdes P; Rojas-Martinez R; Villalpando S; Hernández-Ávila M; Aguilar-Salinas CA
Cardiovasc Diabetol; 2011 Jan; 10():1. PubMed ID: 21214916
[TBL] [Abstract][Full Text] [Related]
18. Prediction of mortality and macrovascular complications in type 2 diabetes: validation of the UKPDS Outcomes Model in the Casale Monferrato Survey, Italy.
Pagano E; Gray A; Rosato R; Gruden G; Perin PC; Merletti F; Bruno G
Diabetologia; 2013 Aug; 56(8):1726-34. PubMed ID: 23680916
[TBL] [Abstract][Full Text] [Related]
19. The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) Study.
Kengne AP; Patel A; Colagiuri S; Heller S; Hamet P; Marre M; Pan CY; Zoungas S; Grobbee DE; Neal B; Chalmers J; Woodward M;
Diabetologia; 2010 May; 53(5):821-31. PubMed ID: 20157695
[TBL] [Abstract][Full Text] [Related]
20. A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68).
Clarke PM; Gray AM; Briggs A; Farmer AJ; Fenn P; Stevens RJ; Matthews DR; Stratton IM; Holman RR;
Diabetologia; 2004 Oct; 47(10):1747-59. PubMed ID: 15517152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
